• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov26
Enlivex Therapeutics Ltd. Completes $212 Million Private Placement to Advance Clinical Development
13:03
Nov15
Enlivex Therapeutics released FY2025 9 Months Earnings on November 14 (EST), with actual revenue of USD 0 and EPS of USD -0.3216
04:00
Enlivex Therapeutics released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0917 (forecast USD -0.12)
04:00
Aug30
Enlivex Therapeutics released FY2025 Semi-Annual earnings on August 29 (EST), actual revenue USD 0, actual EPS USD -0.2234
03:00
Enlivex Therapeutics released FY2025 Q2 earnings on August 29 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0799 (forecast USD -0.16)
03:00
Jun10
Enlivex Therapeutics to Present Knee Osteoarthritis Cell Therapy Data at EULAR Conference
12:33

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -2.205 M, EPS -0.0917

Aug29
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -1.868 M, EPS -0.0799

May30
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -3.452 M, EPS -0.1499

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
HYNE
14.000
+40.00%
+4.000
ASTX
46.070
+36.50%
+12.320
View More